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Key Points Summary: 
 Lymphatic valve defects are one of the major causes of lymph transport dysfunction; 
however, there are no accessible methods for quantitatively assessing valve function. 
 This manuscript provides a novel technique for quantifying lymphatic valve back-leak.  
 Postnatal endothelial-specific deletion of Cx43 in Cx37-/- mice results in rapid 
regression of valve leaflets and severe valve dysfunction. 
 This method can also be used for assessing the function of lymphatic valves from 
various species, including humans.  
 
ABSTRACT 
The lymphatic system relies on robust, spontaneous contractions of collecting lymphatic 
vessels and one-way secondary lymphatic valves to efficiently move lymph forward. 
Secondary valves prevent reflux and allow for the generation of propulsive pressure during 
each contraction cycle. Lymphatic valve defects are one of the major causes of lymph 
transport dysfunction. Genetic mutations in multiple genes have been associated with the 
development of primary lymphedema in humans and many of the same mutations in mice 
result in valve defects that subsequently lead to chylous ascites or chylothorax. At present 
the only experimental technique for the quantitative assessment of lymphatic valve function 
utilizes the servo-null micropressure system, which is highly accurate and precise, but 
relatively inaccessible and difficult to use. We developed a novel, simplified alternative 
method for quantifying valve function and determining the degree of pressure back-leak 
through an intact valve in pressurized, single-valve segments of isolated lymphatic vessels. 
With this diameter-based method, the competence of each lymphatic valve is challenged 
over a physiological range of pressures (e.g. 0.5-10 cmH2O) and pressure back-leak is 
extrapolated from calibrated, pressure-driven changes in diameter upstream from the valve. 
Using mesenteric lymphatic vessels from C57BL/6J, Ub-CreERT2;Rasa1fx/fx, Foxc2+/-, Lyve1-
Cre;Cx43fx/fx, and Prox1-CreERT2;Cx43fx/fx;Cx37-/- mice, we tested our method on lymphatic 
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incompetent. Our results were validated by simultaneous direct measurement of pressure 
back-leak using a servo-null micropressure system. Our diameter-based technique can be 
used to quantify valve function in isolated lymphatic valves from a variety of species. 
Keywords: Lymphatic vessel, back-leak, valve function, servo-null micropressure system, 
lymph transport, Connexin37, Connexin43, Foxc2, Rasa1 
INTRODUCTION 
Secondary lymphatic valves are located throughout networks of collecting lymphatic vessels 
and function to facilitate unidirectional movement of lymph centrally toward the great veins. 
Functional lymphatic valves are critical in preventing back flow in the face of a gravitational 
load, but also in supine body positions because even then lymph is transported against a 
slight adverse pressure gradient (Hargens & Zweifach, 1976). Multiple genetic mutations 
including FOXC2, RASA1, and PIEZO1 lead to human primary lymphedema as a result of 
lymphatic valve defects, as revealed by murine models recapitulating the human gene 
defects (Sabine et al., 2015; Lapinski et al., 2017; Nonomura et al., 2018).  
Quantitative measurements of lymphatic valve function in mice are invaluable in 
distinguishing the cause of lymphatic transport dysfunction, which can potentially be caused 
by a number of factors, including contractile dysfunction (Castorena-Gonzalez et al., 2018b), 
defective lymphangiogenesis (Karkkainen et al., 2000), and/or abnormal valves (Sabine et 
al., 2015; Lapinski et al., 2017; Nonomura et al., 2018). In vivo observations of back flow in 
lymphatic networks, e.g. using tracers, can be indicators of valve dysfunction but may also 
be misleading because a brief period of back flow occurs normally during the lymphatic 
contraction cycle and because lymphatic valves are biased to be open when the trans-valve 
pressure gradient is zero or even fractionally adverse (Davis et al., 2011a). Likewise, more 
sophisticated in vivo methods such as optical coherence tomography, which can provide 
information about valve dynamics (Blatter et al., 2018) if a valve is properly orientated, 
cannot provide quantitative information about back-leak or valve stiffness in the absence of 
pressure measurement/control. Without pressure information, the complicated relationship 
between vessel diameter and the pressure difference required for valve closure (Davis et al., 
2011b; Scallan et al., 2013; Lapinski et al., 2017) can lead to a misinterpretation of valve 
function. 
We previously devised two ex vivo tests for quantifying normal and abnormal valve function 
in rat and mouse collecting lymphatic vessels (Davis et al., 2011a; Lapinski et al., 2017). A 
vessel segment containing a single valve is cannulated at each end (requiring ~40 µm-tip 
micropipettes in mouse vessels) and, using independent pressure control at each end, valve 
behavior is observed under an inverted microscope. 1) In the first method, the adverse 
pressure required to close an open valve is tested in response to a ramp-wise increase in 
outflow pressure while inflow pressure is held constant (Davis et al., 2011a); this test 
provides information about the material properties of the valve (e.g. stiffness), which may 
change if critical valve leaflet components are deleted. Normal mouse and rat valves require 
from 0.1 to ~3 cmH2O adverse pressure gradient to close, while defective valves may 
require >30 cmH2O or never close. 2) In the second method, pressure back-leak through a 
closed valve is measured by inserting a sharpened servo-nulling micropipette (~3-5 µm tip) 
through the vessel wall into the lumen upstream from the valve while the valve is challenged 
by elevation of outflow pressure (Sabine et al., 2015; Lapinski et al., 2017); the degree of 
pressure back-leak is a measure of valve competency, i.e. how well the leaflets seal. A 
servo-null micropipette measurement (Wiederhielm et al., 1964) is needed to detect changes 
in lumenal pressure behind the closed valve because the amount of back flow (nL/min) is 
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Normal mouse valves show little or no pressure back-leak in the latter test, whereas 
defective valves (Foxc2-, Rasa1-, Gja1-, Gata2-deficient) show a range of back-leak from 
mild (Munger et al., 2017; Cha et al., 2018) to severe (Sabine et al., 2015; Lapinski et al., 
2017). It is anticipated that mutations or deficiencies in other genes (including those coding 
for Gja4, Gjc2 and other junctional proteins between lymphatic endothelial cells (LECs) may 
lead to varying degrees of lymphatic valve back-leak that can only be quantified by the back-
leak test. However, servo-null micropressure systems are no longer available commercially, 
are difficult to use, and require extensive training for proper use and calibration, making that 
method inaccessible to most laboratories. For this reason, we devised a method for 
quantifying valve back-leak that does not require a servo-nulling micropressure system. 
Comparison of this novel, diameter-based method with the servo-null method in a large set 
of normal and defective mouse mesenteric lymphatic valves  gave excellent agreement over 
a range of adverse pressure gradients (0.5 to 5 cmH2O, spanning the presumed 
physiological range (Castorena-Gonzalez et al., 2018b)), allowing quantitative measurement 
of valve back-leak in a cannulated lymphatic vessel from a simple diameter measurement.  
METHODS 
Study Approval. All animal protocols and procedures were approved by the University of 
Missouri Animal Care and Use Committee and conformed to the US Public Health Service 
policy for the humane care and use of laboratory animals (PHS Policy, 2011). 
Mice. Both female and male mice were used for the experiments included in these studies. 
Mice were housed in groups of 2-4 mice per cage at a temperature of 22-25oC under a 12-
hour light/dark cycle. Mice had access to food (PicoLab RodentDiet 20 Cat. No. 355043) and 
water at all times. Mice were anesthetized by intraperitoneal injection of Ketamine/Xylazine 
(0.1 mL/25 g) and placed on a heated tissue dissection/isolation pad. To ensure adequate 
anesthesia level prior and during dissection, indicators of pain were continuously monitored 
by assessing loss of pedal and pinna reflexes. At the end of the dissection, animals were 
euthanized via intracardiac KCl injection. Data were collected from the following mouse 
lines: WT (C57BL/6J purchased from The Jackson Laboratory – Bar Harbor, MA, USA), Ub-
CreERT2;Rasa1fx/fx (obtained from Philip D. King, University of Michigan), Foxc2-Cre 
(obtained from Sathish Srinivasan, OMRF), Lyve1-Cre;Cx43fx/fx, Prox1-
CreERT2;Cx43fx/fx;Cx37-/- mice generated in house by crossing Cx37-/-, Cx43fx/fx mice (Simon 
et al., 1997; Liao et al., 2001) and Prox1-CreERT2 mice. Prox1-CreERT2 mice were obtained 
from Taija Mäkinen, University of Uppsula, Sweden. Prox1-CreERT2;Cx43fx/fx;Cx37-/- mice 
were induced via feeding tamoxifen-containing chow (ENVIGO TD.130855) for one week 
(~40 mg/kg of body weight per day assuming a 20-25 g body weight and a 3-4 g intake); and 
experiments were conducted 5-7 days post-induction. Ub-CreERT2;Rasa1fx/fx mice were 
studied 4-5 months post-induction. 
Vessel Isolation, Pressure Myography, and Data Acquisition. Mesenteric lymphatic 
vessels were isolated as previously described (Scallan & Davis, 2013; Scallan et al., 2016; 
Zawieja et al., 2017; Castorena-Gonzalez et al., 2018a; Castorena-Gonzalez et al., 2018b; 
Zawieja et al., 2018). Each vessel was pinned down with short segments of 40 µm stainless 
steel wire onto the Sylgard-coated surface of a dissection chamber filled with BSA containing 
Krebs buffer at room temperature. The large majority of the adipose and connective tissues 
surrounding the lymphatic vessels were cleared by micro-dissection. The vessel was then 
transferred to a 3-mL observation chamber containing BSA containing Krebs buffer, 
cannulated, and pressurized to 3 cmH2O, under no-flow conditions, using two glass 
micropipettes. For all experiments used in this study, we used the same pair of inflow and 
outflow pipettes, maintaining their orientation; inside diameter for each was ~40 µm. 
Micropipettes were mounted onto the micro-manipulator arm pipette holders of a Burg-style 
V-track pipette system. To ensure accurate diameter tracking, the cannulated vessel 
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segments contained a single valve. The pipette system with cannulated lymphatic vessel 
segment was transferred onto the XY-stage of an inverted microscope for observation. 
Polyethylene tubing was attached to the back of each glass micropipette and then connected 
to a microfluidic flow control system (Elveflow OB1 MK3, Paris) with attached low-pressure 
transducers. To minimize longitudinal bowing and associated diameter-tracking artifacts at 
higher intraluminal pressures, input (Pin) and output (Pout) pressures were briefly set to 10 
cmH2O at the beginning of every experiment, and the vessel segment was stretched axially 
to remove longitudinal slack. The vessel was then allowed to equilibrate at 37°C for 20-30 
minutes in a Ca2+-free Krebs buffer while both input and output pressures were set to 3 
cmH2O. Constant perfusion with Ca
2+-free Krebs buffer was maintained using a peristaltic 
pump at a rate of 0.5 mL/min. Custom-written LabVIEW programs (National Instruments; 
Austin, TX) acquired real-time analog data and digital video and detected the inner and outer 
diameter of the vessel (Davis et al., 2006). Videos were recorded for further analyses in 
brightfield mode at 30 fps using a Basler acA2000-340km camera.  
Solutions and Chemicals. Krebs buffer contained: 146.9 mM NaCl, 4.7 mM KCl, 2 mM 
CaCl2·2H2O, 1.2 mM MgSO4, 1.2 mM NaH2PO4·H2O, 3 mM NaHCO3, 1.5 mM Na-HEPES, 
and 5 mM D-glucose (pH = 7.4). An identical buffer was prepared with the addition of 0.5% 
bovine serum albumin (BSA). During cannulation Krebs -BSA buffer was present both 
luminally and abluminally; however, during the experiment the abluminal solution was 
exchanged with Ca2+-free Krebs buffer (in which 3 mM EGTA replaced calcium). All 
chemicals were obtained from Sigma-Aldrich (St. Louis, MO), with the exception of BSA (US 
Biochemicals; Cleveland, OH), MgSO4 and Na-HEPES (ThermoFisher Scientific; Pittsburgh, 
PA). 
Servo-Null Micropressure System. In single-valve lymphatic segments superfused with 
Ca2+-free Krebs buffer to prevent spontaneous contractions, intraluminal pressure was 
directly measured using a servo-null micro-pressure system, as described in detail 
previously (Sabine et al., 2018). Briefly, servo-null micropipettes (∼2 μm tip diameter) were 
pulled from borosilicate glass (1.0/0.5 mm outer diameter/inner diameter, Omega-dot; 
Frederick Haer, Bowdoin, ME) using a Sutter P-97 puller (Sutter Instrument, Novato, CA). 
The pipettes were back-filled with 2 M NaCl and connected to a servo-null micropressure 
system (model 4A; IPM, La Mesa, CA) to monitor intraluminal pressure in the input side of 
the lymphatic segment (upstream from the valve being tested). After the vessel was allowed 
to equilibrate in Ca2+-free Krebs buffer at 37°C, the servo-null system was zeroed with the 
micropipette positioned just outside the vessel wall, the luminal pressure was briefly set to 
10 cmH2O and the vessel was impaled on the inflow side of the valve with a servo-null 
micropipette, positioned via a Narishige MO-102 micromanipulator (Lapinski et al., 2017). A 
small hole was first made with a tapered pilot pipette before inserting the servo-null pipette. 
Successful micropuncture left the servo-null pipette tip free from obstruction in the vessel 
lumen. The servo-null calibration was checked and adjusted, if needed, by briefly raising Pin 
and Pout to 10 cmH2O. 
Identification of Appropriate Diameter Measurement Sites from Space Time Maps 
(STMs). Brightfield videos of the single-valve lymphatic segments during back-leak tests 
were analyzed to generate 2-dimensional maps (STMs) representing the measurement of 
the outside diameter (encoded in 8-bit grayscale and displayed using a colored LUT) over 
time (horizontal axis) at every position along the vessel (vertical axis). To measure the 
outside diameter over time along the entire vessel segment, 30-fps bright-field videos were 
processed frame by frame; a threshold was dynamically applied to each frame and the 
lymphatic walls were then detected via contour detection. Edge detection of the identified 
walls allowed determination of the distance between the outside edges of the lymphatic wall 
at each specific position along the longitudinal axis. Colored maps were created from 8-bit 
grayscale maps using the Physics LUT from ImageJ where blue and red colors represent the 
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dimensional analyses were performed using a set of custom-written Python-based 
programs. These analysis tools were developed from previously published methods for GI 
studies (Hennig et al., 2010; Hennig et al., 2015; Hennig, 2016) and recently adapted for 
lymphatic vessel studies (Castorena-Gonzalez et al., 2018b).  
Calculated Parameters. For a given k-th pressure, the cross-sectional distensibility (DCS) is 
calculated as previously described (Foote et al., 2016):  
DCS=ΔCSA/(CSAi x ΔP),  
where CSA is the cross-sectional area of the lymphatic vessel, ΔCSA=CSAk-CSAi, and 
ΔP=Pk-Pi. The i-th index points to the initial, baseline state (i.e. under 0.5 cmH2O of 
intraluminal pressure). 
Back-leak of pressure through a given valve was assessed when each valve was challenged 
with an output pressure of 5 cmH2O while input pressure was set at 0.5 cmH2O. Therefore, 
pressure back-leak was referenced to this initial input pressure (i.e. back-leak is the 
difference from the 0.5 cmH2O baseline). 
The accuracy of each measurement of pressure back-leak was determined by calculating 
the difference between the gold-standard servo-null method and the diameter-based 
method, and defined as:  
Error = |PBack-leak,Servo-Null-PBack-leak,Diameter-Based|, 
the accuracy was then calculated as: 
% Accuracy = (Error/ PBack-leak,Servo-Null) x 100%. 
The precision of a given back-leak calculation is directly associated with the calculated 
standard-deviation of repeated, consecutive measurements of pressure back-leak for a 
given lymphatic valve. 
STATISTICS 
The number n refers to the total number of experiments (i.e. single-valve lymphatic 
segments) included in this study. In most cases, more than one lymphatic segment from the 
same mouse was successfully studied. Statistical significance between groups was 
assessed via two-Way ANOVA with correction for multiple comparisons using Dunnett’s test. 
Results are reported as mean ± standard deviation with significance set at p<0.05. 
Correlation between measurements obtained with servo-null and the diameter-based 
method here described was determined via analysis of linear correlation (2-tailed, 95% 
confidence interval). The Pearson’s correlation coefficient (r) is reported for the entire data 
set (i.e. n=41). All statistical analyzes were performed using GraphPad Prism 8. 
RESULTS 
Characterization of Pressure-Driven Diameter Changes in Single Valve Lymphatic 
Segments   
Single-valve lymphatic vessel segments were cannulated and pressurized as described 
above at 37oC in Ca2+-free Krebs (Figure 1A). Each lymphatic vessel was allowed to 
equilibrate under no flow conditions (Pin=Pout) at an intraluminal pressure of 3 cmH2O while 
perfused with a Ca2+-free Krebs solution and warmed up to 37oC for 20-30 minutes. After 
impalement and positioning of a servo-null micropipette, intraluminal pressure then was set 
to 0.5 cmH2O and vessel diameter was allowed to reach a steady level. Pressure ramps 
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Changes in diameter were tracked live within a region of interest (Figure 1C) and brightfield 
videos of the entire lymphatic segment were recorded for further analysis. Two-dimensional 
maps from outside diameter line-scans (STMs) were generated (Figure 1D). These maps 
allowed determination of vessel diameter changes as a function of pressure along the entire 
lymphatic segment under study (i.e. in both valve and non-valve areas).  
Next, changes in vessel diameter were measured while the function and competence of 
each lymphatic valve was tested by subjecting the vessel to an adverse increasing (ramp-
wise) pressure (i.e. Pin=0.5 cmH2O and Pout=[0.5,10] cmH2O), Figure 2A. In fully competent 
(i.e. tight) valves, increasing the output pressure caused the valves to close at low Pout 
values (0.6-0.7 cmH2O) after which the output side of the lymphatic segment subsequently 
distended (Figure 2B). Importantly, even though the closed valve successfully prevented 
pressure back-leak into the input side (i.e. servo-null pressure remained at ~0.5 cmH2O), the 
distention of the valve sinus area resulted in a non-pressure driven increase in vessel 
diameter in the upstream region immediately adjacent to the base of the valve (Figure 2B,D-
E). However, apart from that area, the change in diameter on the input side of the valve was 
negligible (Figure 2C), as evident by the blue colors throughout the entire output pressure 
ramp (Figure 2E). In contrast, increasing the output pressure (Figure 3A) in lymphatic 
segments containing a very leaky valve resulted in back-leak of pressure into the input side 
(i.e. servo-null pressure in the input side read ~5.1 cmH2O when output pressure reached 10 
cmH2O) with concomitant enlargement of the vessel diameter throughout the entire segment 
(Figure 3B-E). As anticipated, away from the valve area, the distention of the vessel 
diameter on the input side depended on the degree of dysfunction of the valve and the 
associated pressure back-leak (Figure 3B,C). Therefore, we developed a simplified method 
to quantify the back-leak of pressure based on diameter changes upstream from a tested 
valve. It is important to note that the 2-dimensional STMs shown in Figures 1-3 are not 
necessary for calculation of back-leak of pressure using the method described in the 
following section; however, they help identify the optimal location along the lymphatic vessel 
to record changes in diameter. The STMs in Figures 2-3 show that diameter measurement at 
the input side of the vessel (upstream from the valve) and away from the valve sinus 
provides a reliable indicator of pressure back-leak.  
Assessment of Lymphatic Valve Back-leak Using Pressure-Driven Changes in 
Diameter 
To quantify the degree of pressure back-leak from the diameter change, a servo-null 
micropipette was positioned in the lumen of the input side, upstream from the valve (Figure 
4A), Pin and Pout were set to 0.5 cmH2O and vessel diameter was allowed to reach a steady 
level. As shown in Figure 4A, outside diameter was tracked on the input side, near the input 
cannulating pipette and away from the valve area. Calibration curves were obtained by 
simultaneously increasing both input and output pressure in a ramp-wise manner from 0.5 to 
10 cmH2O (Figure 4B) while outside diameter was recorded and expressed as change in 
outside diameter (Figure 4C). In order to subsequently assess the back-leak of pressure 
through the valve undergoing testing, back-leak test curves were obtained by increasing Pout 
in a ramp-wise manner from 0.5 to 10 cmH2O while keeping Pin constant at 0.5 cmH2O 
(Figure 4E). Under these conditions, intraluminal pressure measured by the servo-null 
micropipette (Figure 4D) and outside diameter were recorded at the input side as a function 
of the increasing output pressure. It is critical that both calibration and back-leak curves are 
obtained from diameter tracking at the same position along a given lymphatic vessel. We 
decided to use the calculated change in diameter as it was a better indicator of pressure 
change (Figure 4F). Calibration and back-leak test curves were repeated 3 times each in an 
alternating manner. In order to minimize hysteresis in the pressure-diameter curve, prior to 
each pressure ramp (either calibration or back-leak test), the vessel wall was unloaded by 
briefly setting intraluminal pressure to 0 cmH2O for about 10 seconds, and then diameter 
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steady level). Back-leak of pressure was calculated from the change in diameter as follows: 
1) from the back-leak test pressure ramp (Figure 4E), for a given/selected output pressure 
value, its corresponding time label was identified. In the example shown in Figure 4, back-
leak of pressure is calculated when output pressure was equal to 5 cmH2O (Figure 4E); 2) 
the time label associated with the specific testing pressure (i.e. ~0.7 min) was mapped onto 
the change in the outside diameter curve (Figure 4F); 3) subsequently, that change in 
outside diameter value (i.e. 7.89 µm) was compared to the calibration trace of the change in 
diameter (Figure 4C); 5) and finally, this change in diameter value was mapped onto its 
corresponding calibration pressure ramp (Figure 4B) to identify the intraluminal pressure 
level that would cause such change in outside diameter. In this example, the diameter-based 
method allowed us to determine a diameter-based pressure of 1.09 cmH2O (i.e. pressure 
back-leak equals 0.59 cmH2O – pressure difference from baseline), which is very 
comparable with the actual pressure measurement from the servo-null recording (1.06 
cmH2O, from Figure 4D). This method and the specific experimental example shown in 
Figure 4 is also visually described in Supplemental Video 1 (back-leak test) and 
Supplemental Video 2 (calibration curve).  
Back-leak Pressure Measurements on Mesenteric Lymphatic Valves: Endothelium-
Specific Deletion of Connexin43 in Connexin37 Globally-Deficient Mice Results in Full 
Regression of Lymphatic Valves   
In the mouse, mesenteric valves are widely used in studies assessing the role of genes 
controlling valve development and valve maintenance. This is in part due to the extensive 
number of lymphatic vessels and lymphatic valves that are present in the mesentery and the 
ease of imaging these valves. However, determining the degree of competency of lymphatic 
valves requires graded measurement of valve function, which remains undetermined for 
mesenteric valves.  Therefore, we assessed the degree of pressure back-leak using isolated 
mesenteric lymphatic valves from WT (C57BL/6J control, fully-functional valves); and, Ub-
CreERT2;Rasa1fx/fx, Foxc2Cre/+, Lyve1-Cre;Cx43fx/fx, and Prox1-CreERT2;Cx43fx/fx;Cx37-/- mice. 
These genes (i.e. Rasa1, Foxc2, Cx43, and Cx37) have previously been linked to lymphatic 
valve dysfunction associated with immaturely formed or regressed valve leaflets. In order to 
validate our diameter-based method, simultaneous measurements were performed using a 
servo-null micropressure system and compared the results with diameter-based 
extrapolation. As in the previous section, 3 sets of calibration and back-leak test curves were 
recorded, with each value in each back-leak test curve compared to all calibration curves. 
Pressure back-leak was determined when valves were challenged with an adverse (output) 
pressure equal to 5 cmH2O, while input pressure was maintained at 0.5 cmH2O, and 
calculated back-leak was compared to the corresponding servo-null measurement (Figure 
5A,B). Importantly, measurements of pressure back-leak using both servo-null and the 
diameter-based method were statistically comparable (i.e. data is linearly correlated, 
Pearson’s correlation coefficient r=0.9839, p<0.05). The fully-functional (non-leaky) and 
mildly leaky valves are located in the bottom left corner in Figure5A (inside dashed box). A 
zoomed-in view of these values is shown in Figure 5B. In Figure 5A, the dotted straight line 
represents the ideal scenario (i.e. slope = 1), where both our diameter-based method and 
the servo-null microsystem would provide identical pressure back-leak values. In Figures 
5A,B, data are shown as the mean ± standard-deviation for each experiment (a total of “n” 
experiments were performed for each group); and Figure 5E shows all individual data-points 
for each group. 
Our data from WT and Rasa1-deficient mesenteric valves (Figure 5A,B,E) confirm the 
findings of our previous studies in popliteal lymphatics: essentially no back-leak (i.e. normal 
function) of WT valves and ~50% of Rasa1-deficient valves with nearly complete back-leak 
(Lapinski et al., 2017). Likewise, lymphatic endothelium-specific Cx43-deficient (i.e. Lyve1-
Cre;Cx43fx/fx) valves showed a wide range of phenotypes from tight to intermediate back-leak 
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et al., 2017). Data from two new genotypes of mice for which back-leak has not previously 
been assessed are also reported in Figure 5: Foxc2Cre/+ valves, which are haplodeficient in 
Foxc2, and Prox1-CreERT2;Cx43fx/fx;Cx37-/- valves deficient in both Cx43 (postnatal deletion) 
and Cx37, the two most widely expressed connexin isoforms in lymphatic endothelial cells 
(LECs) (Kanady et al., 2011; Meens et al., 2014). In a previous study, we reported that 
complete knockout of Foxc2 from LECs results in a high percentage of completely 
incompetent valves with severely shortened leaflets (Sabine et al., 2015); it is therefore 
somewhat surprising that Foxc2 haplodeficient (Foxc2Cre/+) valves do not show an 
intermediate back-leak phenotype but rather are almost normal (Figure 5A,B,E), at least 
when valves are challenged with an outflow pressure of 5 cmH2O. This suggests that 
complete or nearly complete deletion of Foxc2 is required to produce a severe valve defect. 
In contrast, postnatal, endothelium-specific deletion of Cx43 (using the Prox1-CreERT2 
driver) in Cx37-globally-deficient (Cx37-/-) mice produced severe valve regression, up to the 
point that long segments (~5 mm) of mesenteric lymphatic vessels could be observed with 
apparent sinuses but no valves; such segments otherwise should have contained 3-5 valves. 
In other cases, shorter segments like the ones studied here had varying degrees of leaflet 
regression, from partial leaflets to short stubs where leaflets once were present (Figure 5D), 
in contrast to fully-formed, competent valves in WT vessels (Figure 5C). Since these vessels 
were studied only 5-7 days after the mouse was induced with tamoxifen (i.e. following the 
end of a week-long induction period), this is the most rapid instance of valve regression 
described so far; faster than LEC-specific Foxc2-deficient (Foxc2LECKO) mice in which some 
valves remained after 4 weeks (Sabine et al., 2015) and faster than Rasa1LECKO mice in 
which some valves remained after 5 months (Lapinski et al., 2017).  
Accuracy and Precision of the Diameter-Based Back-Leak Measurement 
We then evaluated the accuracy and precision of the diameter-based method for calculating 
pressure back-leak. Since this method relies on the accurate detection of changes in 
diameter driven by changes in intraluminal pressure, we first determined and compared the 
cross-sectional distensibility of each lymphatic segment included in this study. The cross-
sectional distensibility is a parameter that measures the degree of diameter change due to a 
given change in intraluminal pressure. Similar to blood vessels, lymphatics from different 
anatomical regions display different mechanical characteristics. When examining the cross-
sectional distensibility of mesenteric lymphatics from the different groups included here, we 
found that lymphatic vessels from Foxc2Cre/+ mice were significantly more distensible than 
vessels from all the other groups (Figure 6A). We then proceeded to calculate the accuracy 
and the precision of our diameter-based measurements of pressure back-leak. The 
precision, indicative of measurement reproducibility, is directly associated with the standard 
deviation of a given set of collected repeated, consecutive measurements on the same 
sample. Our analysis shows that this simplified diameter-based method is both highly 
accurate and precise as evident by the respective low error and standard deviation values 
(Figure 6B,C). While there are no-significant differences in error and standard deviation 
between groups, there appeared to be a correlation between cross-sectional distensibility 
and accuracy; this is indicated by the higher distensibility and lower error values (higher 
accuracy) obtained for vessels from Foxc2Cre/+ mice (Figure 6A,B). In general, lymphatic 
vessels from the various strains displayed higher cross-sectional distensibility in the range of 
pressure from 1 to 3 cmH2O (Figure 6A). This becomes highly important in vessels 
containing incompetent valves (e.g. lymphatic valves from Ub-CreERT2;Rasa1fx/fx, Lyve1-
Cre;Cx43fx/fx, and Prox1-CreERT2;Cx43fx/fx;Cx37-/- mice), where the pressure back-leak ≥ 3 
cmH2O, and consequently the distensibility is minimal, thereby limiting accurate and precise 
measurement of diameter changes. While not significantly different, there was a tendency for 
precision to decrease (i.e., higher standard-deviation values) as pressure back-leak 
increased (Figure 6C). Finally, the percent accuracy as a function of the precision (standard-
deviation) was calculated (Figure 6D). Here, clustering of data-points in the upper-left corner 
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higher percent accuracy) and high precision (i.e. 80% of the measurements fall within a 
standard deviation of 0.2 cmH2O or lower) associated with the measurement of pressure 
back-leak using our diameter-based method.  
 
Discussion 
Abnormal fluid accumulation associated with lymphatic dysfunction can result from impaired 
contractility of collecting lymphatics and/or incompetent lymphatic valves that cannot cope 
with the chronic adverse hydrostatic pressure load imposed by gravitational forces 
(Olszewski & Engeset, 1980; Olszewski, 2002; Modi et al., 2007; Stanton et al., 2009; Ferrell 
et al., 2010; Kanady et al., 2011; Ostergaard et al., 2011; Finegold et al., 2012; Sabine et al., 
2012; Brice et al., 2013; Geng et al., 2016). At present, the single technique capable of 
quantifying back-leak through intact isolated lymphatic valves uses the servo-null 
micropressure system (Davis et al., 2011a; Lapinski et al., 2017), which: 1) is difficult to 
learn, 2) requires instrumentation that is no longer available commercially; 3) involves the 
insertion of a servo-null pipette that can be easily plugged if not inserted through a pre-made 
hole in the vessel wall made with a pilot pipette; and 4) requires a 45o-angle 
micromanipulator. Here we have developed, tested, and validated a simplified method that 
utilizes the pressure-driven changes in vessel passive diameter to calculate pressure back-
leak through a lymphatic valve being studied using pressure myography. Outside diameter 
recording was used simultaneously with servo-null micropressure measurement to test and 
validate our method; however, we also confirmed that inner diameter tracking gave 
comparable results. We used outside over inner diameter tracking because outside diameter 
tracking can easily be achieved using various already available, open-source tools: 
VasoTracker (Lawton et al., 2019), ImageJ, etc. In addition to reporting novel findings on 
valve function/dysfunction in lymphatic valves from Foxc2Cre/+ and Prox1-
CreERT2;Cx43fx/fx;Cx37-/- mice, the significance of this work comes in making available a 
more accessible technique for quantitative measurement of lymphatic valve function. This 
novel method was tested in a large set of mesenteric lymphatic valves displaying a wide 
range of dysfunction. However, this method could be adapted easily, with minor 
modifications, to study lymphatic valves from different anatomical regions or from other 
species, including humans. Our method should also be applicable to studies of venous valve 
function.      
Mesenteric valves have been the target for several developmental studies to assess the role 
of critical transcriptional factors that control valve development and maintenance. Such 
studies typically rely on imaging techniques to quantify valve density within the lymphatic 
vasculature and/or identify abnormal looking valves. Conclusions about abnormal valve 
appearance can be complicated by valve orientation and, in mature animals, by the 
presence of overlying connective and adipose tissue; in any case, they do not assess actual 
valve function.  
Our method is capable of quantitatively assessing lymphatic valve competency (i.e. pressure 
back-leak) with high accuracy and high precision. As our method relies on the ability to 
measure changes in vessel wall diameter that result from changes in intraluminal pressure, 
the distensibility of a vessel will determine the working range and accuracy of back-leak 
measurements. This is important, because lymphatic vessels from different beds display 
different degrees of distensibility; and consequently, the accuracy of this method may be 
different for lymphatic vessels from different areas of the body. In general, lymphatics are 
more distensible in the lower range of pressure (i.e. 1-3 cmH2O). This is directly correlated 
with the degree of accuracy of our diameter-based method to assess lymphatic valve 
function such that measurements are accurate in the low range of pressures but become 




This article is protected by copyright. All rights reserved. 
 
range, accuracy, and precision of the diameter-based measurement of pressure back-leak 
should be taken into consideration when comparing valve function in vessels from mice with 
different genotypes and/or phenotypes in which distensibility could change along with valve 
function. For example, arterial/arteriolar distensibility has been reported to be altered in 
obesity, diabetes, and hypertension (Reneman & Hoeks, 1995; Van Bortel et al., 1995; 
Tentolouris et al., 2003; Bender et al., 2015; Foote et al., 2016; Ljunggren et al., 2016); and 
lymphatic vessel distensibility (although not reported under those conditions) could change 
as well. Such changes could easily be accounted for in valve function studies by measuring 
vessel distensibility curves (obtained during valve function tests) for the various genotypes. 
A requirement of our method and the servo-null method to detect back-leak is having an 
inflow pipette with a relatively high hydraulic resistance, allowing pressure to rise between 
the valve and the tip of the inflow pipette, in which pressure is held at 0.5 cmH2O. Pipettes 
with different resistances would lead to differences in the determination of the amount of 
back-leak for a given valve. For this reason, we were careful, as in previous studies, to use 
the same pairs of inflow and outflow pipettes for all experiments, i.e. for all 41 valve tests in 
the 5 different genotypes of mice. This limitation would need to be taken into consideration in 
future studies investigating venous valves or larger lymphatic vessels, e.g. from humans. 
We validated our diameter-based method by assessing the function of a large set of 
mesenteric valves displaying a wide range of competency, i.e. normal, fully-competent 
valves from C57BL/6J mice to varying degrees of leaky, incompetent valves from Ub-
CreERT2;Rasa1fx/fx, Foxc2Cre/+, Lyve1-Cre;Cx43fx/fx, and Prox1-CreERT2;Cx43fx/fx;Cx37-/- mice. 
Here we showed that haplodeficiency in Foxc2 (Foxc2Cre/+) does not seem to be sufficient to 
cause significant valve dysfunction compared to when Foxc2 is completely deleted from 
LECs. We also showed that postnatal endothelial-specific deletion of Cx43 in Cx37-/- mice 
resulted in rapid (5-7 days post induction) regression of valve leaflets and severe valve 
dysfunction. A regression of lymphatic valve leaflets this rapid has not been reported 
previously. Our present work did not include a survival study; however, a small group (~4 
mice) of Prox1-CreERT2;Cx43fx/fx;Cx37-/- mice died 2-3 weeks after Cx43-deletion was 
induced via tamoxifen feeding. In a few cases, even after only 7 days post-induction, we 
observed bloody mesenteric lymphatic nodes and blood-filled mesenteric lymphatic vessels. 
This is important because, global, embryonic deletion of both Cx43 and Cx37 in the mouse 
prevents normal lymphatic valve development. Cx43-/-;Cx37-/- embryos are not viable and 
display blood-filled lymphatic vasculature and severe edema (Kanady et al., 2011); however, 
the end cause of death may also be associated with developmental cardiac abnormalities 
related to the global deletion of Cx43 (Reaume et al., 1995). Therefore, our findings show for 
the first time, that in mature/adult mice, both Cx43 and Cx37 play a critical role in lymphatic 
valve maintenance; and sudden deletion of endothelial-Cx43 in global Cx37-deficient mice 
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Figure 1. Pressure-driven changes in vessel diameter. A) Isolated, cannulated, and 
pressurized single-valve mesenteric lymphatic vessel segment from the mouse with 
independent control of input and output pressures (i.e. Pin and Pout respectively). B) Double 
(i.e. input and output) pressure ramp traces. C) Outside diameter (O.D.) as a function of 
pressure recorded from the single tracking window shown in the top panel. D) Space time 
map (STM) generated from an outside diameter line scan showing the change in diameter 
as a function of time (horizontal axis) along the entire lymphatic segment (position is 
indicated on the vertical axis and it aligns with the vessel image shown on the left side) as 
pressure increases in a ramp-wise manner (panel B). Outside diameter is encoded in a 
color-scale as indicated to the right of the heat map. The time (horizontal) axis is matched in 
panels B-D. Vessel wall diameter changes are determined as a function of pressure by 
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Figure 2. Pressure-driven changes in vessel diameter in a mesenteric lymphatic 
segment containing a single, fully-competent valve. A) Ramp-wise increase in output 
pressure (0.5-10 cmH2O) while input pressure is held constant at 0.5 cmH2O. B) STM 
generated from outside diameter tracking (encoded in a color-scale) for a fully-competent, 
single-valve mesenteric lymphatic segment as a function of time/pressure. Vessel image 
preparations on both left and right side of the colored STM show the vessel at the initial 
(Pin=Pout=0.5 cmH2O) and final (Pin=0.5 cmH2O and Pout=10 cmH2O) states. C) Outside 
diameter (O.D.) tracking as a function of time/pressure recorded at a single site upstream 
from the valve (tracking window shown in panel B); diameter remains significantly 
unchanged even when the pressure downstream from the valve (i.e. output pressure) 
reaches 10 cmH2O. Zoomed-in insert shows an initial distension of the vessel wall at the 
onset of the pressure ramp and sudden drop in vessel diameter after the lymphatic valve 
closes as a result of the adverse pressure gradient. D) Image from an actual lymphatic 
vessel preparation showing a fully-competent (i.e. tight) valve preventing pressure back-leak 
when output pressure reaches 10 cmH2O; input pressure remains constant at 0.5 cmH2O as 
measured by servo-null micropressure system. E) Same image with outside diameter 
encoded in a multi-color scale, showing how a fully-competent valve prevents pressure 
back-leak and results in negligible distention of the lymphatic wall upstream from the valve, 
while vessel diameter reaches maximum distention downstream from the valve where output 
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Figure 3. Pressure-driven changes in wall diameter in a mesenteric lymphatic 
segment containing a single valve displaying a significant degree of dysfunction. A) 
Ramp-wise increase in output pressure (0.5-10 cmH2O), with input pressure being held 
constant at 0.5 cmH2O. B) STM generated from outside diameter tracking (encoded in a 
color-scale) as a function of time/pressure for a mesenteric lymphatic segment containing a 
highly dysfunctional, single valve. Vessel images on the left and right sides of the STM show 
the vessel at the initial (Pin=Pout=0.5 cmH2O) and final pressures, respectively. C) Outside 
diameter (O.D.) tracking as a function of time/pressure recorded at a single site upstream 
from the valve (see panel B for location of tracking window). Consistent and significant 
increase in vessel diameter as pressure downstream from the valve (Pout) increases from 0.5 
to 10 cmH2O, resulting in back-leak into the input side. D) Image of a lymphatic vessel 
preparation with significant pressure back-leak, as evident by vessel wall distention at the 
input side when output pressure reaches 10 cmH2O. While input pressure was set to 0.5 
cmH2O actual pressure in the input side reached ~5.1 cmH2O (determined by servo-null 
system) as a result of substantial pressure back-leak through the dysfunctional valve. E) 
Outside diameter encoded in a multi-color scale. Diagram shows how pressure back-leak 
results in distention of the entire lymphatic segment, which contrasts with distention of the 
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Figure 4. Diameter-based method for extrapolating pressure back-leak through a 
single, intact valve in an isolated, cannulated, and pressurized lymphatic vessel. A) 
Single-valve lymphatic segment showing a single-site diameter tracking window and a servo-
null glass micropipette to record intraluminal pressure. In this example, this valve displayed 
an intermediate degree of dysfunction (i.e. partial leak). Servo-null pipette positioned in 
vessel lumen after micropuncture of the lymphatic wall at the input side near the input 
pipette. B) Calibration pressure ramp generated by simultaneously increasing both input and 
output pressure in a ramp-wise manner (0.5 to 10 cmH2O). C) Trace of the change in 
outside diameter as a function of time as pressure increases during the calibration pressure 
ramp (as shown in B). D) Intraluminal pressure, from servo-null micropipette recording, 
showing increase in intraluminal pressure as output pressure rises (as shown in E) and leaks 
back into the input side through the partially defective valve. E) Back-leak test pressure ramp 
in which output pressure is increased in a ramp-wise manner from 0.5-10 cmH2O, while 
input pressure is held constant at 0.5 cmH2O. F) Trace of the change in outside diameter as 
a function of time and as output pressure is increased. Numbers represent each one of the 4 
steps needed for pressure back-leak calculation. Briefly, 1) a test pressure is selected from 
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mapped to obtain the corresponding change in outside diameter value from the trace in F 
(i.e. 7.89 µm); 3) this diameter is compared to the calibration change in the diameter trace in 
C; and finally, the time label associated with this calibration diameter value is mapped onto 
the calibration pressure ramp, panel B, to determine the intraluminal pressure (i.e. 1.09 
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Figure 5. Assessment of pressure back-leak in mesenteric valves displaying various 
degrees of valve dysfunction. The degree of pressure back-leak was determined in single 
valves from WT, Ub-CreERT2;Rasa1fx/fx, Foxc2-Cre, Lyve1-Cre;Cx43fx/fx, or Prox1-
CreERT2;Cx43fx/fx;Cx37-/- mice at 5 cmH2O adverse (output) pressure. A) Calculated pressure 
back-leak (measurement referenced to the initial input pressure of 0.5 cmH2O) using the 
diameter-based method plotted as a function of the corresponding measured pressure back-
leak from a servo-null micropressure recording. Dotted line represents the ideal one-to-one 
correlation (i.e. slope = 1); servo-null and diameter-based method measurements are 
linearly correlated with a Pearson’s correlation coefficient r=0.9839, p<0.05. Values are 
reported as the mean ± standard-deviation of 9 repeated measurements that result from 
matching 3 back-leak tests with each of 3 calibration ramps. B) Zoomed-in view of the dotted 
box shown in panel A (both normal valves and valves displaying a low-to-intermediate 
degree of dysfunction). Calculation of pressure back-leak using changes in outside diameter 
upstream from the valve gives accurate and precise values as evident from the 
corresponding servo-null micropressure measurements. C) Representative image of a 
mesenteric lymphatic vessel from a WT mouse showing a fully-formed, competent valve. D) 
Representative image of a mesenteric lymphatic vessel from a Prox1-
CreERT2;Cx43fx/fx;Cx37-/- mouse showing a severely defective valve where leaflets have 
almost completely regressed. E) Pressure back-leak measurements per group, with all 
individual data points shown. * Indicates statistical significance (p<0.5) when compared to 
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Figure 6. Lymphatic vessel distensibility and assessment of the accuracy and 
precision of the diameter-based method. A) Group comparison of the cross-sectional 
distensibility as a function of intraluminal pressure for all of the mesenteric lymphatic vessels 
included in this study. Foxc2-haplodeficient vessels display significantly higher distensibility. 
In general, all lymphatics are more distensible in the lower range of pressure (<3 cmH2O). * 
Indicates statistical significance (p<0.5) when compared to WT controls using a two-way 
ANOVA test. B) Calculated error (absolute difference between the pressure back-leak 
measurements obtained with a servo-null system and using the diameter-based method). 
Values measured using a servo-null system are considered the gold-standard/accepted 
reference. The lower the error, the higher the accuracy of the diameter-based method. C) 
Precision of the calculated pressure back-leak is directly associated with the standard-
deviation resulting from 9 repeated measurements (matching 3 back-leak tests with 3 
calibration ramps). In B and C, results are reported as mean ± standard-deviation and box-
height is given by the minimum and maximum value observed in each group. Lower 
precision (larger standard-deviation values) is observed in measurements of pressure back-
leak in valves displaying higher degree of dysfunction. D) Percent accuracy plotted as a 
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